DoW Parkinson's, Early Investigator Research Award
This grant funds early-career researchers studying Parkinson’s disease, offering two levels: mentored fellowships and independent investigator awards, both aligned with PRP focus areas but not supporting clinical trials.
Browse similar grants
Funder: Defense Health Agency Contracting Activity - DHACA
Due Dates: October 23, 2026 (Letter of intent) | November 6, 2026 (Full application) | November 13, 2026 (Recommendations and verification)
Funding Amounts: Up to $300,000 (Level 1) or $1 million (Level 2) in total costs for up to 2 years
Summary: Supports early-career investigators conducting Parkinson’s disease research to decrease risk, slow progression, or ease symptoms.
Key Information: A pre-application is required, and clinical trials are not allowed.
Description
The FY26 Parkinson’s Research Program (PRP) Early Investigator Research Award supports investigators developing careers in Parkinson’s disease research, including those without previous experience in the field. Managed by the Congressionally Directed Medical Research Programs (CDMRP) and solicited by DHACA, it aims to expand research capacity and address understudied areas through innovative, high-impact ideas and technologies. Two funding levels distinguish mentored fellows from early-career independent investigators.
The program seeks research that translates into clinically meaningful treatments and benefits people with, or at risk for, Parkinson’s disease. Applications must explain how the research will decrease the disease’s burden on Service Members, dependents, Veterans, and other military beneficiaries. Enrolling military beneficiaries is not required, but the research must be applicable to them.
